Sort   by:  
 Page size 
UnknownSwitch to fixed-dose ainuovirine, lamivudine, and tenofovir DF versus elvitegravir, cobicistat, emtricitabine, and tenofovir alafenamide in virologically suppressed people living with HIV-1: the 48-week results of the SPRINT trial, a multi-centre, randomised, double-blind, active-controlled, phase 3, non-inferiority trial.
Not available
S-EPMC11293588 | biostudies-literature
UnknownImmediate and delayed switches to tenofovir DF-containing, ainuovirine-based antiretroviral regimen: the SPRINT extensional study.
Not available
S-EPMC12482040 | biostudies-literature
UnknownImmediate and long-term outcomes after treat-all among people living with HIV in China: an interrupted time series analysis.
Not available
S-EPMC10424386 | biostudies-literature
Sort   by:  
 Page size